Belvedere Trading
CDLX icon

Belvedere Trading’s Cardlytics CDLX Stock Holding History

Belvedere Trading’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.42K Buy
+761
New +$5.69K ﹤0.01% 999
2024
Q2 		– Sell
-1,105
Closed -$160K – 718
2024
Q1 		$160K Buy
+1,105
New +$93.3K ﹤0.01% 370
2023
Q3 		– Sell
-733
Closed -$46.3K – 692
2023
Q2 		$46.3K Buy
+733
New +$44.4K ﹤0.01% 558

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.88B AUM 2.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return
WPM
Worldly Partners Management Needham, Massachusetts $122M AUM 11.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.41B AUM 39.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $2.16B AUM 28.56% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Belvedere Trading's CDLX Position: Q2 2026 in Review

Belvedere Trading opened a new position in Cardlytics (CDLX) in Q2 2026: 761 shares worth $3.42K. The stake represents ﹤0.01% of the portfolio and ranks #999 among its holdings. This is a return to the name: Belvedere Trading previously reported a position in CDLX as recently as Q1 2024.

Belvedere Trading first reported a position in CDLX in Q2 2023 and has held it in 3 quarters since. The position peaked at $160K in Q1 2024. 42 funds tracked by Wall St. Rank hold CDLX as of Q2 2026.

  • Belvedere Trading held 761 shares of Cardlytics worth $3.42K as of Q2 2026.
  • Cardlytics was a new Belvedere Trading position in Q2 2026.
  • Cardlytics made up ﹤0.01% of Belvedere Trading's portfolio in Q2 2026, its #999 holding.
  • Belvedere Trading first reported a position in Cardlytics in Q2 2023 and has held it in 3 quarters since.
  • Belvedere Trading's Cardlytics position peaked at $160K in Q1 2024.
  • 42 funds tracked by Wall St. Rank held Cardlytics as of Q2 2026.

Based on Belvedere Trading's 13F filing for Q2 2026, filed 31 Jul 2026.